Todd W. Garner - Mar 1, 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Executive Vice President & CFO
Signature
Sarah M. Oliker for Todd W. Garner by Power of Attorney
Stock symbol
CNMD
Transactions as of
Mar 1, 2023
Transactions value $
-$46,734
Form type
4
Date filed
3/3/2023, 06:13 PM
Previous filing
Dec 12, 2022
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +1.6K +160000% $0.00 1.6K Mar 1, 2023 Direct
transaction CNMD Common Stock Tax liability -$46.7K -486 -30.36% $96.16 1.12K Mar 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -1.6K -100% $0.00* 0 Mar 1, 2023 Common Stock 1.6K $0.00 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +32.2K $0.00 32.2K Mar 1, 2023 Common Stock 32.2K $96.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period